Carlson, Robert H.
Almost 90 percent of youngsters along with acute lymphoblastic leukemia (ALL) can easily be cured today along with the usage of glucocorticoids as induction therapy. The glucocorticoids prednisone and dexamethasone have actually been compared directly as induction therapy in several randomized clinical trials, yet it has actually not been clear whether one is superior to the other.
acute lymphoblastic …
Image Tools
The answer might depend, according to a recent report from the AIEOP-BFM Every one of 2000 trial (Associazione Italiana di Ematologia e Oncologia Pediatrica–Berlin-Frankfurt-Munster (AIEOP-BFM), on which portion of “superior” one means.
In efficacy, the usage of dexamethasone in the induction phase of treatment for pediatric Every one of in AIEOP-BFM Every one of 2000, fairly compared to standard prednisone, led to a one-third reduction in the relapse rate—the 5-year cumulative incidence of relapse was 15.6 percent for prednisone versus 10.8 percent for dexamethasone. yet in terms of safety, dexamethasone additionally increased mortality prior to finish response plus mortality in initial finish response related to treatment, a total of 2.5 percent versus 0.9 percent for prednisone. And 5-year overall survival was virtually identical: 90.3 percent for dexamethasone versus 90.5 percent for prednisone. The data were published recently in Blood (127;2101-2112).
First author Anja Möricke, MD, Department of Pediatrics at the University Medical Focus Schleswig-Holstein, Kiel, Germany, reported that the only overall survival incentive seen along with dexamethasone joined the subset of patients along with T-cell Every one of and good early treatment response.
The study included 3,7twenty youngsters and adolescent patients from age 1 to 17 years diagnosed along with Every one of in one of the 127 participating study centers in Austria, Germany, Italy, and Switzerland.
Patients in this open-label study were randomly assigned to receive standard glucocorticoid therapy along with prednisone (60 mg/m2 per day) or dexamethasone (10 mg/m2 per day) as portion of a four-drug induction therapy. Between July 1, 2000 and July 31, 2006, 1,853 patients were randomly assigned to the dexamethasone arm and 1,867 patients to the prednisone arm. The primary outcome was event-free survival.
ALL Study Results
Relapse Rates: The 5-year cumulative incidence of relapse was 10.8 percent in the dexamethasone study arm versus 15.6 percent in the prednisone arm group, along with the largest effect on extramedullary relapses.
Event-Free Survival: The incentive of dexamethasone was partially counterbalanced by a significantly better induction-related death rate, resulting in 5-year event-free survival rates of 83.9 percent for dexamethasone and 80.8 percent for prednisone.
Overall Survival: No difference was seen in 5-year overall survival—dexamethasone 90.3 percent versus prednisone 90.5 percent.
However, there was a considerable overall survival incentive from dexamethasone in patients along with T-cell Every one of that had an excellent response to the prednisone pre-phase, 91.4 percent for dexamethasone versus 82.6 percent for prednisone.
“In patients along with precursor B-cell Every one of and good response to the prednisone pre-phase, survival after relapse was significantly worse if patients were previously assigned to the dexamethasone arm,” the researchers reported.
The study’s senior author, Martin Schrappe, MD, Chair of General Pediatrics at the University Medical Focus Schleswig-Holstein, noted that prednisone was used in pre-phase since its prognostic value has actually been prospectively determined in earlier trials of the ALL-BFM group. Such data are not available for dexamethasone, he said; therefore, it would certainly be a significant mistake to replace prednisone along with dexamethasone free of such data.
“We had hoped that patients that did not respond adequately to prednisone in the pre-phase would certainly have actually a incentive from dexamethasone, yet this was not the case.”
Life-threatening events in the dexamethasone arm included bacterial (primarily gram-negative rods) also as fungal (primarily molds) infections. There was additionally a better incidence of life-threatening neurologic and gastrointestinal complications in dexamethasone-treated patients.
Primary Endpoint Choice
The researchers said their data suggest trials using event-free survival as the primary endpoint to evaluate front-line treatments might be influenced by survival after relapse.
“However, using overall survival as the only endpoint bears the risk that triumph or failure of the relapse treatment could distort the effect of the tested therapy,” they added. An overall-survival endpoint would certainly additionally require better patient numbers to reach sufficient statistical power, and several pediatric Every one of trials would certainly be underpowered—“as is the case in our trial.”
The authors acknowledge using event-free survival as a primary endpoint to evaluate a front-line treatment is a limitation of this study, yet they additionally point out using overall survival as the only endpoint would certainly mean that efficacy of treatments used for relapse could have actually biased the effect of dexamethasone.
ALL Interventions
In a commentary in Blood accompanying the study (2016;127:2049-2051) by Stephen P. Hunger, MD, Chief of the Division of Oncology at the University of Pennsylvania and Director of the Focus for Childhood Cancer Research, Children’s Hospital of Philadelphia, noted that the one-third reduction in relapse risk along with usage of dexamethasone is the greatest reduction seen in BFM trials in the past 40 years.
“On balance, dexamethasone is the drug of choice…right?” Appetite wrote. “Not so fast—the devil is in the details, and the Outcomes of this study have actually complex implications for Exactly how we think of Every one of therapy in the 21st century.”
Hunger speculates dexamethasone improved event-free survival yet not overall survival since much more patients treated initially along with prednisone were salvaged adhering to relapse.
“This makes sense for two reasons—first, dexamethasone had its greatest effect on preventing extramedullary relapses, which are even more salvageable compared to marrow relapses. And second, several of the relapses prevented by dexamethasone were those that occurred after completion of therapy, and [it is known that] youngsters along with relapsed Every one of are even more curable once relapse, even marrow relapse, occurs after completion of therapy compared to once relapse occurs throughout primary therapy.”
The relapses prevented were the ones that could not be salvaged easily along with current therapeutic approaches, Appetite wrote. “For this group, dexamethasone is clearly much better compared to prednisone.”
So even though questions still continue to be concerning Exactly how to optimally usage glucocorticoids in pediatric Every one of therapy, Appetite said, “a fundamental lesson of this trial is the should identify interventions that stay away from early bone marrow relapses. Such interventions will certainly most likely boost survival, which is the supreme target of Every one of therapy.”
Robert H. Carlson is a contributing writer.
Copyright © 2016 Wolters Kluwer Health, Inc. Every one of rights reserved.
